4.3 Article

Comparative interactomics analysis reveals potential regulators of α6β4 distribution in keratinocytes

Journal

BIOLOGY OPEN
Volume 9, Issue 8, Pages -

Publisher

COMPANY BIOLOGISTS LTD
DOI: 10.1242/bio.054155

Keywords

Integrin; Interactome; BioID; Hemidesmosome; Cortical microtubule stabilizing complex; Tetraspanin

Categories

Funding

  1. Netherlands Organization for Scientific Research (NWO) [824.14.010]
  2. Dutch Cancer Society [2013-5971]

Ask authors/readers for more resources

The integrin alpha 6 beta 4 and cytoskeletal adaptor plectin are essential components of type I and type II hemidesmosomes (HDs). We recently identified an alternative type II HD adhesion complex that also contains CD151 and the integrin alpha 3 beta 1. Here, we have taken a BioID proximity labeling approach to define the proximity protein environment for alpha 6 beta 4 in keratinocytes. We identified 37 proteins that interacted with both alpha 6 and beta 4, while 20 and 78 proteins specifically interacted with the alpha 6 and beta 4 subunits, respectively. Many of the proximity interactors of alpha 6 beta 4 are components of focal adhesions (FAs) and the cortical microtubule stabilizing complex (CMSC). Though the close association of CMSCs with alpha 6 beta 4 in HDs was confirmed by immunofluorescence analysis, CMSCs have no role in the assembly of HDs. Analysis of the beta 4 interactome in the presence or absence of CD151 revealed that they are strikingly similar; only 11 different interactors were identified. One of these was the integrin alpha 3 beta 1, which interacted with alpha 6 beta 4 more strongly in the presence of CD151 than in its absence. These findings indicate that CD151 does not significantly contribute to the interactome of alpha 6 beta 4, but suggest a role of CD151 in linking alpha 3 beta 1 and alpha 6 beta 4 together in tetraspanin adhesion structures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Tetraspanin CD151 and integrin α3β1 contribute to the stabilization of integrin α6β4-containing cell-matrix adhesions

Lisa te Molder, Juri Juksar, Rolf Harkes, Wei Wang, Maaike Kreft, Arnoud Sonnenberg

JOURNAL OF CELL SCIENCE (2019)

Article Cell Biology

Hemidesmosomes modulate force generation via focal adhesions

Wei Wang, Alba Zuidema, Lisa te Molder, Leila Nahidiazar, Liesbeth Hoekman, Thomas Schmidt, Stefano Coppola, Arnoud Sonnenberg

JOURNAL OF CELL BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Crosstalk between Cell Adhesion Complexes in Regulation of Mechanotransduction

Alba Zuidema, Wei Wang, Arnoud Sonnenberg

BIOESSAYS (2020)

Article Dermatology

Integrin α3β1 Is a Key Regulator of Several Protumorigenic Pathways during Skin Carcinogenesis

Veronika Ramovs, Ana Krotenberg Garcia, Maaike Kreft, Arnoud Sonnenberg

Summary: This study reveals the crucial role of integrin alpha 3 beta 1 and CD151 in regulating signaling pathways that control the survival of differentiating keratinocytes, shedding light on the essential role of alpha 3 beta 1 in the early stages of skin cancer development.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Article Oncology

Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer

Isabel Mayayo-Peralta, Beatrice Faggion, Liesbeth Hoekman, Ben Morris, Cor Lieftink, Isabella Goldsbrough, Lakjaya Buluwela, Joseph C. Siefert, Harm Post, Maarten Altelaar, Roderick Beijersbergen, Simak Ali, Wilbert Zwart, Stefan Prekovic

Summary: Treatment resistance and disease progression are common challenges in breast cancer patients, particularly those with mutations in the oestrogen receptor-alpha gene. This study identifies ribociclib as an effective inhibitor for breast cancer cells, inducing senescence and reducing sensitivity to chemotherapy. Additionally, the maintenance of cell viability through the EGFR signaling pathway following ribociclib treatment offers potential therapeutic opportunities.

CANCERS (2021)

Article Cell Biology

Molecular determinants of αVβ5 localization in flat clathrin lattices - role of αVβ5 in cell adhesion and proliferation

Alba Zuidema, Wei Wang, Maaike Kreft, Onno B. Bleijerveld, Liesbeth Hoekman, Jonas Aretz, Ralph T. Boettcher, Reinhard Faessler, Arnoud Sonnenberg

Summary: In this study, the researchers investigate the subcellular distribution of alpha V beta 5 integrin in keratinocytes and find that it can reside in two distinct adhesion structures - focal adhesions (FAs) and flat clathrin lattices (FCLs). They identify the proteins that regulate the distribution of beta 5 and demonstrate that changes in cellular contractility and microtubule disruption can affect its localization. The study also shows that beta 5 in both FAs and FCLs plays a role in promoting adhesion, cell spreading, and proliferation.

JOURNAL OF CELL SCIENCE (2022)

Article Cell Biology

PEAK1 Y635 phosphorylation regulates cell migration through association with Tensin3 and integrins

Alba Zuidema, Paul Atherton, Maaike Kreft, Liesbeth Hoekman, Onno B. Bleijerveld, Nagarjuna Nagaraj, Nanpeng Chen, Reinhard Fassler, Arnoud Sonnenberg

Summary: Integrins mediate cell adhesion and growth factor receptor signal transduction through interactions with PEAK1, Tensin3, and Shc1.

JOURNAL OF CELL BIOLOGY (2022)

Editorial Material Biochemistry & Molecular Biology

What does it take to be a collagen receptor?

Richard Farndale, Arnoud Sonnenberg, C. Michael DiPersio, Johannes A. Eble, Jyrki Heino, Donald Gullberg

MATRIX BIOLOGY (2022)

Article Medicine, Research & Experimental

Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity

Stefan Prekovic, Theofilos Chalkiadakis, Merel Roest, Daniel Roden, Catrin Lutz, Karianne Schuurman, Mark Opdam, Liesbeth Hoekman, Nina Abbott, Tanja Tesselaar, Maliha Wajahat, Amy R. Dwyer, Isabel Mayayo-Peralta, Gabriela Gomez, Maarten Altelaar, Roderick Beijersbergen, Balazs Gyorffy, Leonie Young, Sabine Linn, Jos Jonkers, Wayne Tilley, Theresa Hickey, Damir Vareslija, Alexander Swarbrick, Wilbert Zwart

Summary: The glucocorticoid receptor (GR) plays a crucial role in cancer biology. Our study demonstrates that GR activity is related to the proliferative capacity of various primary cancer types and has implications for patient outcomes in breast cancer. We also reveal that GR interacts with estrogen receptor (ER) and affects the chromatin distribution of ER. The activation of GR leads to epigenetic remodeling and upregulation of the ZBTB16 gene, which controls growth in ER-positive breast cancer.

EMBO MOLECULAR MEDICINE (2023)

Article Oncology

Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence

Esmee P. Hoefsmit, Franziska Vollmy, Elisa A. Rozeman, Irene L. M. Reijers, Judith M. Versluis, Liesbeth Hoekman, Alexander C. J. van Akkooi, Georgina Long, Dirk Schadendorf, Reinhard Dummer, Maarten Altelaar, Christian U. Blank

Summary: Taking into account the higher response rates of neoadjuvant immune checkpoint blockade (ICB) in stage III melanoma compared to stage IV disease, researchers hypothesized that systemic immune suppression may be responsible for lower response rates and disease recurrence. Through proteomic profiling, they found that the protein LRG1 is associated with worse prognosis and can serve as a biomarker for identifying high-risk patients and as a potential target for neoadjuvant ICB therapy.

CANCER RESEARCH COMMUNICATIONS (2023)

Article Oncology

Absence of integrin 31 promotesthe progression of HER2-driven breast cancer in vivo

Veronika Ramovs, Pablo Secades, Ji-Ying Song, Bram Thijssen, Maaike Kreft, Arnoud Sonnenberg

BREAST CANCER RESEARCH (2019)

No Data Available